{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:22:14Z","timestamp":1788790934259,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cpcardiol.2026.103430","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:52:02Z","timestamp":1787640722000},"page":"103430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Device-detected atrial fibrillation after ARTESiA and NOAH-AFNET 6: from episode burden to net clinical benefit"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4246-0980","authenticated-orcid":false,"given":"Jordan","family":"Llerena-Velastegui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Jimbo-Sotomayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Chavez-Ruales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Zambrano-Herdoiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.cpcardiol.2026.103430_bib0001","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.1161\/CIR.0000000000000740","article-title":"Subclinical and device-detected atrial fibrillation: pondering the knowledge gap: a scientific statement from the American heart association","volume":"140","author":"Noseworthy","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103430_bib0002","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/europace\/eux163","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103430_bib0003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.cpcardiol.2026.103430_bib0004","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103430_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2026.05.033","article-title":"Direct oral anticoagulants in primary and secondary prevention of thrombotic events: 2026 ACC Scientific statement: a report of the American college of cardiology","author":"Kumbhani","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103430_bib0006","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high-rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the mode selection trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103430_bib0007","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103430_bib0008","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103430_bib0009","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of more than 10,000 patients from the SOS AF project","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.cpcardiol.2026.103430_bib0010","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.cpcardiol.2026.103430_bib0011","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103430_bib0012","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103430_bib0013","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/biology11030443","article-title":"Atrial high-rate episodes detected by cardiac implantable electronic devices: dynamic changes in episodes and predictors of incident atrial fibrillation","volume":"11","author":"Imberti","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.cpcardiol.2026.103430_bib0014","doi-asserted-by":"crossref","first-page":"e09","DOI":"10.15420\/aer.2024.11","article-title":"Outcomes of device-detected atrial high-rate episodes in patients with no prior history of atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"Ahmed","year":"2024","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.cpcardiol.2026.103430_bib0015","article-title":"Device-detected atrial high-rate episodes and risk of ischaemic stroke and progression to atrial fibrillation: a systematic review and meta-analysis","volume":"17","author":"D\u2019lima","year":"2026","journal-title":"Int J Stroke Publ Onlin July"},{"issue":"22","key":"10.1016\/j.cpcardiol.2026.103430_bib0016","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.124.069903","article-title":"Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"150","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103430_bib0017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.cpcardiol.2026.103430_bib0018","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103430_bib0019","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1016\/j.hrthm.2025.07.002","article-title":"Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"22","author":"Boriani","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cpcardiol.2026.103430_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/ejhf\/xuag022","article-title":"Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA","author":"Frausing","year":"2026","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.cpcardiol.2026.103430_bib0021","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"issue":"Suppl 4","key":"10.1016\/j.cpcardiol.2026.103430_bib0022","doi-asserted-by":"crossref","first-page":"iv4","DOI":"10.1093\/eurheartjsupp\/suae075","article-title":"et al. Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit","volume":"26","author":"McIntyre","year":"2024","journal-title":"Eur Heart J Suppl"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103430_bib0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jacc.2024.05.002","article-title":"Apixaban vs aspirin according to CHA2DS2-VASc score in subclinical atrial fibrillation: insights from ARTESiA","volume":"84","author":"Lopes","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103430_bib0024","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(24)00475-7","article-title":"Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial","volume":"24","author":"Shoamanesh","year":"2025","journal-title":"Lancet Neurol"},{"issue":"17","key":"10.1016\/j.cpcardiol.2026.103430_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036429","article-title":"Anticoagulation in patients with device-detected atrial fibrillation with and without a prior stroke or transient ischemic attack: the NOAH-AFNET 6 trial","volume":"13","author":"Diener","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103430_bib0026","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/eurheartj\/ehad771","article-title":"Anticoagulation with edoxaban in patients with long atrial high-rate episodes at least 24 hours","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"issue":"46","key":"10.1016\/j.cpcardiol.2026.103430_bib0027","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1093\/eurheartj\/ehae596","article-title":"Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"45","author":"Schnabel","year":"2024","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103430_bib0028","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.hrthm.2025.07.048","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: a subgroup analysis of ARTESiA","volume":"23","author":"Xing","year":"2026","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103430_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euag083","article-title":"Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6","volume":"28","author":"Goette","year":"2026","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103430_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.17213","article-title":"Cost-effectiveness of anticoagulation treatment for subclinical device-detected atrial fibrillation","volume":"9","author":"Winst\u00e9n","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103430_bib0031","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.17220","article-title":"Anticoagulation in device-detected atrial fibrillation\u2014uncertainty and heterogeneity in value","volume":"9","author":"Yu","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103430_bib0032","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103430_bib0033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2023.27188","article-title":"Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial","volume":"331","author":"Kamel","year":"2024","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103430_bib0034","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jamacardio.2025.4151","article-title":"Major bleeding with apixaban vs aspirin: a subanalysis of the ARTESiA randomized clinical trial","volume":"10","author":"Siegal","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"10310","key":"10.1016\/j.cpcardiol.2026.103430_bib0035","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomized controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.cpcardiol.2026.103430_bib0036","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103430_bib0037","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jce.12864","article-title":"Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the REACT.COM pilot study","volume":"27","author":"Passman","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103430_bib0038","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.hrthm.2018.06.027","article-title":"Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: results from the TACTIC-AF pilot study","volume":"15","author":"Waks","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cpcardiol.2026.103430_bib0039","unstructured":"ClinicalTrials.Gov. The rhythm evaluation for AntiCoagulaTion with continuous monitoring of atrial fibrillation (REACT-AF). NCT05836987. Updated April 9, 2026. Accessed August 13, 2026. https:\/\/clinicaltrials.gov\/study\/NCT05836987."},{"issue":"Suppl 1","key":"10.1016\/j.cpcardiol.2026.103430_bib0040","article-title":"Subclinical atrial fibrillation\/atrial high-rate episodes: what significance and decision-making?","volume":"27","author":"Boriani","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.cpcardiol.2026.103430_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2026.1859191","article-title":"Atrial fibrillation burden and oral anticoagulation: a context-dependent framework for net clinical benefit beyond binary AF definitions","volume":"13","author":"Wu","year":"2026","journal-title":"Front Cardiovasc Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:25:13Z","timestamp":1788787513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626001714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0146280626001714"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103430","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Device-detected atrial fibrillation after ARTESiA and NOAH-AFNET 6: from episode burden to net clinical benefit","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103430"}}